Summary
This 8-K filing from Medtronic plc announces key dates and deadlines related to its 2023 Annual General Meeting of Shareholders (AGM). The AGM is scheduled for October 19, 2023, with a record date of August 25, 2023, for determining shareholders eligible to vote. This filing is crucial for investors as it sets the timelines for submitting shareholder proposals and director nominations. Notably, because the AGM date has shifted significantly from the previous year's anniversary, the previously announced deadlines for shareholder actions no longer apply. The company is providing updated timelines to ensure shareholders are aware of the requirements for presenting proposals or nominating directors, whether for inclusion in the proxy materials or for presentation directly at the meeting. Investors interested in actively participating in corporate governance through these avenues should pay close attention to the specified submission deadlines.
Key Highlights
- 1Medtronic's 2023 Annual General Meeting (AGM) is scheduled for October 19, 2023.
- 2The record date for determining shareholders eligible to vote at the AGM is August 25, 2023.
- 3New deadlines for shareholder proposals and director nominations have been established due to the AGM date change.
- 4Shareholder proposals for inclusion in the proxy materials must be submitted by May 10, 2023.
- 5Shareholder proposals and director nominations not for inclusion in proxy materials must be submitted between July 21, 2023, and August 30, 2023.
- 6All shareholder proposals and nominations must be submitted in writing to Medtronic's registered office in Dublin, Ireland.